Literature DB >> 8106685

Atracurium and laudanosine pharmacokinetics in acute renal failure.

J M Hunter1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106685     DOI: 10.1007/bf01708808

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

1.  Resistance to non-depolarizing neuromuscular blocking agents.

Authors:  J M Hunter
Journal:  Br J Anaesth       Date:  1991-11       Impact factor: 9.166

2.  Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.

Authors:  S Ward; N Boheimer; B C Weatherley; R J Simmonds; T A Dopson
Journal:  Br J Anaesth       Date:  1987-06       Impact factor: 9.166

3.  Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit.

Authors:  P M Yate; P J Flynn; R W Arnold; B C Weatherly; R J Simmonds; T Dopson
Journal:  Br J Anaesth       Date:  1987-02       Impact factor: 9.166

4.  Prolonged paralysis following an infusion of alcuronium in a patient with renal dysfunction.

Authors:  C L Smith; J M Hunter; R S Jones
Journal:  Anaesthesia       Date:  1987-05       Impact factor: 6.955

5.  Studies on muscle relaxants during haemodialysis.

Authors:  D Cozanitis; E Haapanen
Journal:  Acta Anaesthesiol Scand       Date:  1979-06       Impact factor: 2.105

6.  Atracurium infusions in patients with renal failure on an ITU.

Authors:  R B Griffiths; J M Hunter; R S Jones
Journal:  Anaesthesia       Date:  1986-04       Impact factor: 6.955

7.  Atracurium: conception and inception.

Authors:  J B Stenlake; R D Waigh; J Urwin; G H Dewar; G G Coker
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

8.  Use of atracurium and vecuronium in patients with oesophageal varices.

Authors:  C F Bell; J M Hunter; R S Jones; J E Utting
Journal:  Br J Anaesth       Date:  1985-02       Impact factor: 9.166

9.  Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs.

Authors:  D J Chapple; A A Miller; J B Ward; P L Wheatley
Journal:  Br J Anaesth       Date:  1987-02       Impact factor: 9.166

10.  Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU.

Authors:  C J Parker; J E Jones; J M Hunter
Journal:  Br J Anaesth       Date:  1988-11       Impact factor: 9.166

View more
  1 in total

Review 1.  Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.

Authors:  H M Bryson; D Faulds
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.